Europe Inhalation Anesthesia Market Size & Outlook

The inhalation anesthesia market in Europe is expected to reach a projected revenue of US$ 514.3 million by 2030. A compound annual growth rate of 6.3% is expected of Europe inhalation anesthesia market from 2024 to 2030.
Revenue, 2023 (US$M)
$334.2
Forecast, 2030 (US$M)
$514.3
CAGR, 2024 - 2030
6.4%
Report Coverage
Europe

Europe inhalation anesthesia market highlights

  • The Europe inhalation anesthesia market generated a revenue of USD 264.5 million in 2022.
  • The market is expected to grow at a CAGR of 9% from 2023 to 2030.
  • In terms of segment, sevoflurane was the largest revenue generating drug in 2022.
  • Isoflurane is the most lucrative drug segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2023 to 2030.


Europe data book summary

Market revenue in 2022USD 264.5 million
Market revenue in 2030USD 525.1 million
Growth rate9% (CAGR from 2022 to 2030)
Largest segmentSevoflurane
Fastest growing segmentIsoflurane
Historical data covered2016 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSevoflurane, Desflurane, Isoflurane, Halothane
Key market players worldwideBaxter International Inc, AbbVie Inc, Fresenius SE & Co KGaA, Sandoz Group AG ADR, Piramal Enterprises, Halocarbon Products Corporation, Lunan Pharmaceutical Group


Other key industry trends

  • In terms of revenue, Europe region accounted for 21.8% of the global inhalation anesthesia market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 411.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Inhalation Anesthesia Market Companies

Name Profile # Employees HQ Website

Europe inhalation anesthesia market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhalation anesthesia market will help companies and investors design strategic landscapes.


Sevoflurane was the largest segment with a revenue share of 63.18% in 2023. Horizon Databook has segmented the Europe inhalation anesthesia market based on sevoflurane, desflurane, isoflurane, halothane covering the revenue growth of each sub-segment from 2018 to 2030.


The inhalation anesthesia market in Europe is characterized by a diverse range of key players, including established pharmaceutical companies and emerging biotech firms. 

Further the inhalation anesthesia market in Europe is experiencing robust growth fueled by several factors increasing surgical volumes, driven by a rising prevalence of chronic diseases and an aging population.

Reasons to subscribe to Europe inhalation anesthesia market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe inhalation anesthesia market databook

  • Our clientele includes a mix of inhalation anesthesia market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe inhalation anesthesia market , including forecasts for subscribers. This continent databook contains high-level insights into Europe inhalation anesthesia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe inhalation anesthesia market size, by country, 2018-2030 (US$M)

Europe Inhalation Anesthesia Market Outlook Share, 2023 & 2030 (US$M)

Europe inhalation anesthesia market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more